4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobolyi, A; Lakatos, K; Merkely, B; Nagy, Z; Nardai, S; Skopál, J | 1 |
1 other study(ies) available for 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Delayed Gelatinase Inhibition Induces Reticulon 4 Receptor Expression in the Peri-Infarct Cortex.
Topics: Animals; Brain Infarction; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Gelatinases; Gene Expression Regulation; GPI-Linked Proteins; Hydroxamic Acids; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Matrix Metalloproteinases; Myelin Proteins; Nerve Tissue Proteins; Nogo Receptor 1; Oligopeptides; Rats; Receptors, Cell Surface; RNA, Messenger | 2016 |